Results 221 to 230 of about 35,117 (307)

Expert Consensus Guidance on the Management of Chemotherapy-Induced Nausea and Vomiting: An Indian Perspective. [PDF]

Cureus
Dhabhar B, Mahapatra PN, Krishna VM, Sarin J, Gupta TC, Samar A, Biswas B, Murli A, Kota R, Bharat S, Tripathi R.   +10 more
europepmc   +1 more source

The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER).

Annals of Oncology, 2012
M. Aapro, A. Molassiotis, M. Dicato, I. Peláez, Á. Rodríguez-Lescure, D. Pastorelli, L. Ma, T. Burke, A. Gu, P. Gascón, F. Roila   +10 more
semanticscholar   +1 more source

Efficacy of paravertebral block on postoperative nausea and vomiting: a meta-analysis of randomized controlled trial. [PDF]

BMC Anesthesiol
Zeng J, Cao Q, Hong A, Gu Z, Jian J, Liang X.   +5 more
europepmc   +1 more source

Continuum-based postoperative nausea and vomiting prophylaxis protocol: Development and real-world implementation checklist. [PDF]

Indian J Anaesth
Singh MP, Gupta A, Bhardwaj S.
europepmc   +1 more source

Efficacy of 5-hydroxytryptamine 3 receptor antagonists versus metoclopramide for preventing nausea and vomiting during azacitidine chemotherapy in patients with myelodysplastic syndromes or acute leukemia: a retrospective observational study. [PDF]

J Pharm Health Care Sci
Wakasugi Y, Ikeda Y, Noda S, Murata M, Morita SY.   +4 more
europepmc   +1 more source

Midazolam: An Effective Antiemetic After Cardiac Surgery???A Clinical Trial

, 2004
Orathy Patangi Sanjay, Deepak Ivan Tauro
openalex   +1 more source

STOP-CINV Study: Safety and Efficacy of IV Akynzeo® (Fosnetupitant 235 mg and Palonosetron 0.25 mg) for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Indian Patients. [PDF]

Cureus
Shukla P, Valame S, Nanda S, Shakya NK, Verma AK, Hanji A, Pednekar A, Bhagat S, Patil S, Petare AU, Bhushan S, Barkate H.   +11 more
europepmc   +1 more source

Inducing emesis in Australian dogs and cats: agents, adverse effects and antiemetic administration. [PDF]

Aust Vet J
Tsitonakis J, Hall E, Quain A.
europepmc   +1 more source

Fosaprepitant for the prevention of multiple-day cisplatin chemotherapy-induced nausea and vomiting: a prospective randomized controlled study. [PDF]

BMC Pharmacol Toxicol
Wang L, Jin G, Wang W, Zhao J, Chen F, Li X, Jiang Y, Zhang Z, Li Q.   +8 more
europepmc   +1 more source

A multicenter randomized open-label phase 2 study investigating optimal antiemetic therapy for patients with advanced/recurrent gastric cancer treated with trastuzumab deruxtecan: the EN-hance study. [PDF]

Int J Clin Oncol
Aoyama T, Ooki A, Oba K, Nishikawa K, Kawabata R, Honda M, Maeda H, Kanda M, Sugiyama K, Makiyama A, Segami K, Takahashi M, Shindo Y, Namikawa T, Oshima T, Katayama A, Shiosakai K, Sakamoto J.   +17 more
europepmc   +1 more source